Oxoid Legionella Pneumo Groups 2-14 Latex Test, DR0802M, containing 50 tests per box. The box contains a variety of components, one of which is Oxoid L. pneumophila Group 2-14 Latex Reagent, Lot 1301912. The product is a latex agglutination test for the identification of predominant Legionella species grown on plate media from patients with suspected Legionellosis or from environmental sources. The test allows a separate identification of Legionella pneumophila serogroup 15 and serogroups 1-14 and detection of other pathogenic non L. pneumophila, Legionella strains.
Published December 3, 2014 · Recall initiated: October 23, 2014
Summary
FDA records medical device Class II recall Z-0465-2015, published December 3, 2014 and initiated October 23, 2014. Recalling firm: Remel Inc; Status: Terminated; Reported quantity: 2/50 test boxes; Lot: DR0802M box lot 1301909, Exp. 30Sep2014. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
A reagent within the test may return false negative results.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Remel Inc
- Distributor
- Nationwide Distribution including AZ, CA, DC, FL, IL, ME, NJ, NY, PA, VA, and VT.
- Lot
- DR0802M box lot 1301909, Exp. 30Sep2014
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAThermo SCIENTIFIC, Sensititre STP6F, Gram Negative IVD ASTDecember 14, 2022
- FDAThio Med w/Dex, Hem, Vit K (5ml) 100/PK Product Usage; Recommended for use in qualitative procedures as aMay 29, 2019
- FDAThio Med w/Dex, Hemin, Vit K (5ml) 20/PK Product Usage: Recommended for use in qualitative procedures as aMay 29, 2019
- FDABlood Agar (TSA w/ 5% Sheep Blood) Plate, For In Vitro Diagnostic Use, Remel, Lenexa, KS 66215 Product Usage:May 3, 2017
- FDAAlignRT- Intended for prescription use. The system is indicated for use during simulation, setup andDecember 3, 2014
- FDAOxoid Legionella Latex Test, DR0800M, containing 50 tests per box. The box contains a variety of components,December 3, 2014
Questions about this recall
Was Oxoid Legionella Pneumo Groups 2-14 Latex Test, DR0802M, containing 50 tests per box. The box contains a variety of components, one of which is Oxoid L. pneumophila Group 2-14 Latex Reagent, Lot 1301912. The product is a latex agglutination test for the identification of predominant Legionella species grown on plate media from patients with suspected Legionellosis or from environmental sources. The test allows a separate identification of Legionella pneumophila serogroup 15 and serogroups 1-14 and detection of other pathogenic non L. pneumophila, Legionella strains. recalled?
Yes. FDA published recall Z-0465-2015 on December 3, 2014. Reported hazard: A reagent within the test may return false negative results.
What should I do if I have this product?
Voluntary: Firm initiated · Letter